Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling Wan

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
Frontiers in Oncology|September 20, 2021
A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid LeukemiaJia Yin, Chao-Ling Wan, Ling Zhang, et al.
Clinical Epigenetics|October 14, 2025
Phase II study of dual epigenetic targeting with chidamide and azacitidine in patients with high-risk acute myeloid leukemia after allo-HSCTYa-Xue Wu, Chao-Ling Wan, Kai-Wen Tan, et al.
Leukemia & Lymphoma|October 6, 2025
Venetoclax plus hypomethylating agents versus priming regimen as the first-line therapy for newly diagnosed acute myeloid leukemia with myelodysplasia-related changes: a propensity score-matched analysisYuan-Hong Huang, Fang-Tong Liu, Chao-Ling Wan, et al.
Schizophrenia Research|March 7, 2021
Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic markerDan-Dan Wang, Xiao-Wen Hu, Jie Jiang, et al.
The Lancet. Gastroenterology & Hepatology|November 12, 2023
Effect of an artificial intelligence-assisted system on endoscopic diagnosis of superficial oesophageal squamous cell carcinoma and precancerous lesions: a multicentre, tandem, double-blind, randomised controlled trialXiang-Lei Yuan, Wei Liu, Yi-Xiu Lin, et al.
BMJ (Clinical Research Ed.)|August 19, 2025
Effect of lateral versus supine positioning on hypoxaemia in sedated adults: multicentre randomised controlled trialHui Ye, Li-Hua Chu, Guo-Hao Xie, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
Frontiers in Oncology|September 20, 2021
A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid LeukemiaJia Yin, Chao-Ling Wan, Ling Zhang, et al.
Clinical Epigenetics|October 14, 2025
Phase II study of dual epigenetic targeting with chidamide and azacitidine in patients with high-risk acute myeloid leukemia after allo-HSCTYa-Xue Wu, Chao-Ling Wan, Kai-Wen Tan, et al.
Leukemia & Lymphoma|October 6, 2025
Venetoclax plus hypomethylating agents versus priming regimen as the first-line therapy for newly diagnosed acute myeloid leukemia with myelodysplasia-related changes: a propensity score-matched analysisYuan-Hong Huang, Fang-Tong Liu, Chao-Ling Wan, et al.
Schizophrenia Research|March 7, 2021
Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic markerDan-Dan Wang, Xiao-Wen Hu, Jie Jiang, et al.
The Lancet. Gastroenterology & Hepatology|November 12, 2023
Effect of an artificial intelligence-assisted system on endoscopic diagnosis of superficial oesophageal squamous cell carcinoma and precancerous lesions: a multicentre, tandem, double-blind, randomised controlled trialXiang-Lei Yuan, Wei Liu, Yi-Xiu Lin, et al.
BMJ (Clinical Research Ed.)|August 19, 2025
Effect of lateral versus supine positioning on hypoxaemia in sedated adults: multicentre randomised controlled trialHui Ye, Li-Hua Chu, Guo-Hao Xie, et al.
Pageof 18